GlaxoSmithKline

$35.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (+1.00%) As of 7:02 PM UTC today

Why Robinhood?

You can buy or sell GSK and other stocks, options, and ETFs commission-free!

About GSK

GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom. The listed name for GSK is GlaxoSmithKline plc.

CEO
Emma N. Walmsley
Employees
99,437
Headquarters
Middlesex, Greater London
Founded
1999
Market Cap
87.10B
Price-Earnings Ratio
11.78
Dividend Yield
5.96
Average Volume
7.40M
High Today
$35.27
Low Today
$34.65
Open Price
$34.79
Volume
4.27M
52 Week High
$43.18
52 Week Low
$31.43

GSK News

MarketWatchMar 5

NIH stops clinical trials for two experimental antibody COVID-19 treatments

The National Institutes of Health said Thursday that it stopped enrollment in two clinical trials evaluating experimental COVID-19 therapies after discovering t

GSK Earnings

$0.00
$0.29
$0.58
$0.87
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 28

You May Also Like

IPOE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure